Prediction of Vancomycin Dose for Recommended Trough Concentrations in Pediatric Patients With Cystic Fibrosis

Area of Science:

• Pharmacology
• Pediatric Medicine
• Infectious Diseases

Background:

• Vancomycin is crucial for treating infections like methicillin-resistant Staphylococcus aureus and those in cystic fibrosis patients.
• Optimizing vancomycin dosing is essential for effective treatment, especially in pediatric populations.
• Current dosing strategies may require adjustments to achieve therapeutic trough levels efficiently.

Purpose of the Study:

• To develop a predictive model for optimal vancomycin dosage in pediatric cystic fibrosis patients.
• To accelerate the achievement of desired vancomycin trough levels through evidence-based dosing.
• To establish a robust model correlating vancomycin dose, patient weight/age, and target trough levels.

Main Methods:

• Development of regression models using transformed dose and trough level data.
• Analysis based on empirical clinical observations in pediatric patients.
• Validation of model robustness against variations in patient age and weight.

Main Results:

• Two regression models demonstrated an excellent fit for predicting vancomycin dose based on weight or age for a target trough level.
• The models indicate that vancomycin dose per kilogram is primarily dictated by the desired trough concentration.
• Specifically, a daily dose of 80 mg/kg is required to achieve a vancomycin trough level of 20 μg/mL.

Conclusions:

• The proposed regression models offer a robust approach to vancomycin dosing in pediatric cystic fibrosis patients.
• Implementing this model can enhance vancomycin therapy efficiency by minimizing dose titration steps.
• This optimized dosing strategy is expected to improve patient outcomes and clinical experience.